Sanofi SA
SWB:SNW2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Sanofi SA (SNW2) under the Base Case is EUR per share.
Compared with the current market price of 43.2 EUR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Sanofi Does
Sanofi is a global healthcare company that discovers, develops, makes, and sells prescription medicines and vaccines. Its main products cover areas like immunology, rare diseases, neurology, diabetes, and infectious diseases, along with preventive vaccines used by doctors, hospitals, public health systems, and pharmacies.
- Headquarters
- France FR
- Employees
- 74 846
- IPO date
- Jul 1, 2002
Sanofi has no economic moat
Patent protection keeps copies of some Sanofi medicines out, but it does not prevent rivals from developing alternative treatments. Competition against older medicines shows that these product-level protections do not provide a lasting shield across the company.
Read the full moat analysis
Earnings Waterfall
Sanofi SA
What is the Intrinsic Value of one SNW2 stock?
The intrinsic value for Sanofi SA (SNW2) under the Base Case is EUR.
Is SNW2 stock undervalued or overvalued?
Compared with the current market price of 43.2 EUR, the stock appears .
